Neuland

Saharsh Davuluri


Continuous Improvement in Drug Manufacturing – Still a Ways to Go

The healthcare industry is driven by scientific innovation, often in response to various public health crises. But while science & discovery often leap forward, the physical act of manufacturing a…

Posted in continuous manufacturing, Pharm Tech, Pharmaceutical Technology, process chemistry | Leave a comment

How to Select a Peptide Synthesis Technique

Peptides are a complex drug class, and have historically proven challenging from a manufacturing standpoint. They are, however, experiencing a renaissance due to improvements in peptide synthesis, the development of…

Posted in API synthesis, Chemistry, CMC, Contract Manufacturing, method development, peptide, Peptide aggregation, peptides, process chemistry | Leave a comment

Leveraging QbD for API Scale Up

Earlier this month we wrote a piece on the Five Challenges Scaling Up an Active Pharmaceutical Ingredient (API). In the post’s conclusion, we discussed the role of QbD in aiding…

Posted in API synthesis, APIs, Design of Experiment, method development, Neuland Labs, QbD, Quality, regulatory, Uncategorized | Leave a comment

5 Common Challenges Scaling Up an API

While linear drug scale-up sounds great on paper, the reality is usually much different. In fact, scaling up an API can be challenging even under the best circumstances. In fact,…

Posted in APIs, CMC, Contract Manufacturing, critical reaction parameters, CRO/CMO, method development, Neuland Labs, particle size, Route Design, Route Scouting, scale-up, synthesis | Leave a comment

Neuland, Corporate Responsibility & the Movement to Eradicate Hunger

As a pharmaceutical company, Neuland has always been committed to impacting life positively across the globe. Whether it is manufacturing products to improve health, or improving the life of its…

Posted in Food waste, Neuland Labs | Leave a comment

Medicine & Science: Keeping Up with the Pace of Change

The changes we’ve witnessed in the fields of science and medicine over the last decade or two have been truly astonishing. When we stood at the beginning of the ‘omics…

Posted in analytical science, API synthesis, Big Data, Capabilities, Chemistry, Neuland Labs, peptide, peptides | Leave a comment

Inside Look: The Role of the IPR Department

Intellectual Property Rights and its Importance in Research, Business & Industry We wrote a post on the patent cliff issue back in 2015. The patent cliff has served to further…

Posted in agreement, Contract Manufacturing, IP, method development, Neuland Labs, Patent, technology transfer | Leave a comment

Reflections on DCAT Week 2017 & AsiaTIDES, Japan

This year’s DCAT Week saw a new format and setting, while Neuland’s first AsiaTIDES show demonstrated the growing importance of peptides to the Japanese & Asian pharma industries. Here are…

Posted in AsiaTIDES, DCAT, Neuland Labs | Leave a comment

5 Variables Shaping the Contract Pharma-Client Relationship

Several posts ago, I discussed an article on the ‘shifting sands’ of contract provider/pharma relationships, and how smart providers were responding to pharma’s needs, rather than establishing fixed models of…

Posted in analytical science, API synthesis, Chemistry, CMC, Contract Manufacturing, CRO/CMO, Neuland Labs | Leave a comment

Defining the Contract Pharma Provider Relationship

I read an article at Pharmaceutical Manufacturing earlier this year (Inking the Deal: Mastering the art of lasting outsourcing relationships in the pharmaceutical industry) on the nature of contract pharma…

Posted in agreement, APIs, Contract Manufacturing, drugs, method development, Neuland Labs, outsourcing, process chemistry, Process Engineering, Project Management | Leave a comment